5 results
management hematology algorithm vte behcets diagnosis disease doac duration dvt length malignancy oncology sjogrens
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis. Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... of cancer-associated ... thrombosis; PE = pulmonary ... #Algorithm #Anticoagulation ... #Management #Hematology
►
 Behcet's Syndrome - Treatment Ulcers: • Treatment: Topical steroids • Prevention: Colchicine • Azathioprine for refractory disease Arthritis:
Behcet's Syndrome ... immunosuppressive meds • +/- Anticoagulation ... Behcets #disease #Syndrome ... #pharmacology # ... rheumatology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease • Superficial Venous Thrombosis • Upper
post-thrombotic syndrome ... Thrombophilia • Cancer ... Bloodman #VTE #anticoagulation ... management #DVT #hematology ... #length #treatment
Sjogren's Syndrome Overview Epidemiology: • F > M: 9:1 • 5-6th Decades (can be any age) Autoimmune exocrinopathy multisystemic disease
Disease: • 10%-15% Pulmonary ... , INC risk PE, Pulmonary ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... #Rheumatology #
Myelodysplastic syndromes current treatment algorithm 2018. From Blood Cancer Journal, Published 24 May 2018 Myelodysplastic syndromes (MDS) are
Myelodysplastic syndromes ... current treatment ... Myelodysplastic syndromes ... risk of clonal evolution ... cardiovascular or pulmonary
No results found for "Evolution pulmonary treatment pediatrics pharmacology syndrome rheumatology cancer anticoagulation"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Evolution #pulmonary #treatment #pediatrics #pharmacology #syndrome #rheumatology #cancer #anticoagulation